🔎 Trials Near Me

Akèy › Maladi poumon entèstisyèl › Oklahoma › Oklahoma City

Etid klinik pou Maladi poumon entèstisyèl nan Oklahoma City, OK

5 etid pou Maladi poumon entèstisyèl ap chèche patisipan nan sit nan ak bò kote Oklahoma City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)

Ap rekriteEtid obsèvasyon
  • The University of Oklahoma Health Sciences Center, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou Aug 26, 2026 · NCT06388421

Idiopathic Pulmonary Fibrosis and Interstitial Lung Disease Prospective Outcomes Registry

Ap rekriteEtid obsèvasyon
  • University of Oklahoma, Oklahoma City
Laj 21 ak plis · Tout sèks · Mizajou Aug 12, 2026 · NCT01915511

Study Evaluating INS018_055 Administered Orally to Subjects With Idiopathic Pulmonary Fibrosis

Ap rekriteFaz 2
  • University of Oklahoma Health Sciences Center (OUHSC), Oklahoma City
Laj 40 ak plis · Tout sèks · Mizajou Nov 12, 2025 · NCT05975983

Study to Evaluate the Efficacy, Safety, and Tolerability of Efzofitimod in Patients With Systemic Sclerosis (SSc)-Related Interstitial Lung Disease (ILD) (SSc-ILD)

Ap rekriteFaz 2
  • aTyr Investigative Site, Oklahoma City
Laj 18 ak plis · Tout sèks · Mizajou May 7, 2025 · NCT05892614

Etid Maladi poumon entèstisyèl nan lòt vil

Lòt etid nan Oklahoma City

Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.